Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
- Author(s)
- Fidelito, G; Watt, MJ; Taylor, RA;
- Journal Title
- Frontiers in Oncology
- Publication Type
- Review
- Abstract
- Prostate cancer invokes major shifts in gene transcription and metabolic signaling to mediate alterations in nutrient acquisition and metabolic substrate selection when compared to normal tissues. Exploiting such metabolic reprogramming is proposed to enable the development of targeted therapies for prostate cancer, yet there are several challenges to overcome before this becomes a reality. Herein, we outline the role of several nutrients known to contribute to prostate tumorigenesis, including fatty acids, glucose, lactate and glutamine, and discuss the major factors contributing to variability in prostate cancer metabolism, including cellular heterogeneity, genetic drivers and mutations, as well as complexity in the tumor microenvironment. The review draws from original studies employing immortalized prostate cancer cells, as well as more complex experimental models, including animals and humans, that more accurately reflect the complexity of the in vivo tumor microenvironment. In synthesizing this information, we consider the feasibility and potential limitations of implementing metabolic therapies for prostate cancer management.
- Keywords
- lipid metabolism; metabolic heterogeneity; metabolic targeting; metabolism; obesity; patient-derived xenograft; prostate neoplasia; commercial or financial relationships that could be construed as a potential; conflict of interest.
- Department(s)
- Laboratory Research
- PubMed ID
- 35127483
- Publisher's Version
- https://doi.org/10.3389/fonc.2021.778761
- Open Access at Publisher's Site
https://doi.org/10.3389/fonc.2021.778761- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-10-24 05:32:26
Last Modified: 2024-10-24 05:33:22